DUBLIN--(BUSINESS WIRE)--The "Global Neuroprosthetics Market - Segmented by Type, Technique, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The global neuroprosthetics market is expected to grow at a CAGR of 12.4% over the forecast period 2018-2023.
Increasing Incidence of Hearing Loss
-
High Cost of Neuroprosthetics & Unfavorable Reimbursement Scenario is
Hampering Growth
- North America to Maintain the Lead in the Global Market
Key Developments in the Market
- The U.S. Food and Drug Administration approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform. The remote programming feature is indicated for patients who have had six months of experience with their cochlear implant sound processor and are comfortable with the programming process.
- Researchers report amputees are able to control a robotic arm with help of brain implants and BMI technology. The study details how brain areas that control both the intact arm and amputated limb can create new connections and learn to control the robotic arm.
- Abbott
- Boston Scientific
- Cochlear
- Livanova
- Med-El
- Medtronic
- Nevro
- Retina Implant
- Second Sight
- Sonova
Key Topics Covered
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/98hpvc/global?w=4